Eduard Fatakhov
Internal Medicine · Alpharetta, GANPI 1295099018
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $311,470 of the $375,743 with a category attached, or 82.9%. Novo Nordisk accounts for 84.9% of it on its own, with 26 other manufacturers making up the rest. Among internal medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 667 payments — averaging $563.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$319K
- Lilly USA, LLC$53K
- AbbVie$846
- Noven Therapeutics, LLC$585
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$402
- Axsome Therapeutics, Inc.$198
- plus $1K from 21 others
What the payments were for
- Consulting fees$3400%
- Speaking & faculty fees$311,47083%
- Travel & lodging$48,17813%
- Food & beverage$15,7274%
- Education$270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 381 | $319,035 |
| Lilly USA, LLC | 110 | $53,401 |
| AbbVie(2 entities) | 41 | $846 |
| Noven Therapeutics, LLC | 45 | $585 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $402 |
| Axsome Therapeutics, Inc. | 9 | $198 |
| Supernus Pharmaceuticals, Inc. | 5 | $194 |
| Amgen | 4 | $164 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $133 |
| Jazz Pharmaceuticals Inc. | 7 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $92 |
| Kvk-tech, Inc. | 1 | $74 |
| Arbor Pharmaceuticals, Inc. | 4 | $63 |
| Antares Pharma, Inc. | 4 | $60 |
| Galderma Laboratories, L.p. | 2 | $53 |
| Eisai Inc. | 4 | $53 |
| Tolmar, Inc. | 2 | $40 |
| Abbott | 2 | $39 |
| AstraZeneca | 2 | $30 |
| Vivus LLC | 2 | $29 |
| Hologic Sales And Service, LLC | 1 | $26 |
| Neos Therapeutics, LP | 2 | $24 |
| Sanofi Pasteur Inc. | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Corcept Therapeutics | 1 | $17 |
| Merck | 1 | $14 |
| Halozyme Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$375,743 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 13 | $109 |
| Atorvastatin Calcium | 15 | $64 |
| Buspirone Hcl | 12 | $25 |
| Clonazepam | 11 | $12 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Alpharetta
- Michael GibsonSmyrna$2.2M
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
- Anna LedfordValdosta$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.